Clinical Trials Directory

Trials / Unknown

UnknownNCT05492760

Evaluation of Recurrence Risk of Atrial Fibrillation After Cryoballoon Ablation

Evaluation of Recurrence Risk of Atrial Fibrillation After Cryoballoon Ablation: a Retrospective Cohort Study

Status
Unknown
Phase
Study type
Observational
Enrollment
600 (estimated)
Sponsor
Shanghai 10th People's Hospital · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The recurrence of atrial fibrillation(AF) after pulmonary vein ablation with cryoballoon is conducted by many factors . The previous studies found larger left atrial and longer AF duration are tied to higher risk of AF recurrence. The characters of ablation procedure is also of critical importance to durable clinical success such as temperature features and time-to-isolation (TTI). The aim of our study is to develop an tool of recurrence risk evaluation with both pre-procedure and procedure factors.

Conditions

Interventions

TypeNameDescription
DEVICEcryoballoon ablationPatients with AF will accept cryoballoon ablation.

Timeline

Start date
2022-08-01
Primary completion
2023-07-01
Completion
2024-07-01
First posted
2022-08-09
Last updated
2022-08-09

Source: ClinicalTrials.gov record NCT05492760. Inclusion in this directory is not an endorsement.